Evidence map›Paper›PMID 41415653›Full record

ArticleJournal of the Korean Society of Radiology2025

Leptomeningeal Enhancement Manifesting as a Treatment-Related Change in Isocitrate Dehydrogenase-Wildtype Glioblastoma Mimicking Leptomeningeal Metastases on Contrast-Enhanced FLAIR MRI: A Case Report.

Ji Hwan Kang, Minchul Kim, Myung Sub Kim, Myung Ho Rho, Kyung Hoon Lee, Jason Joon Bock Lee

Abstract readCase Reports
In one paragraph

Article in Journal of the Korean Society of Radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leptomeningeal metastases in isocitrate dehydrogenase (IDH)-wild-type glioblastoma (GBM) is crucial for determining patient prognosis and treatment plans. Advancements in surgical techniques and concurrent chemoradiotherapy have increased the survival time of patients, resulting in a higher detection rate of leptomeningeal metastases. Evaluation of leptomeningeal metastasis status has traditionally relied on brain MRI, particularly contrast-enhanced T1-weighted images. However, the increasingly used contrast-enhanced fluid attenuated inversion recovery (FLAIR) imaging has demonstrated superior performance in diagnosing leptomeningeal tumor metastases and detecting other lesions. We present a case of leptomeningeal enhancement that regressed on subsequent follow-up without any treatment changes. This condition may be more frequently accounted for when using contrast-enhanced FLAIR.

Indexed as

FLAIRGlioblastomaLeptomeningeal PseudoprogressionRadiation Theraphy

Identifiers

PMID41415653
PMCPMC12710264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.